Literature DB >> 15324949

Treatment of chronic viral hepatitis in patients with renal disease.

Fabrizio Fabrizi1, Paul Martin, Suphamai Bunnapradist.   

Abstract

In the last several years, numerous studies on the natural history and outcomes of viral hepatitis in dialysis and transplantation have been reported. Despite these, the management of hepatitis C virus or hepatitis B virus-related liver disease in end-stage renal disease continues to be an area of controversy. This article aims to address the current therapeutic options for patients with renal disease and chronic viral hepatitis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15324949     DOI: 10.1016/j.gtc.2004.04.011

Source DB:  PubMed          Journal:  Gastroenterol Clin North Am        ISSN: 0889-8553            Impact factor:   3.806


  1 in total

1.  Sustained virological response rate to pegylated interferon plus ribavirin for chronic hepatitis C in African Americans: results in treatment-naïve patients in a university liver clinic.

Authors:  Savita Srivastava; Maria Bertagnolli; James H Lewis
Journal:  J Natl Med Assoc       Date:  2005-12       Impact factor: 1.798

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.